Association of Prior SARS-CoV-2 Infection With Risk of Breakthrough Infection Following mRNA Vaccination in Qatar-Reference-Cited by-同舟云学术

Association of Prior SARS-CoV-2 Infection With Risk of Breakthrough Infection Following mRNA Vaccination in Qatar

Published:2021-11-16 Issue:19 Volume:326 Page:1930
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Abu-Raddad Laith J.¹²³⁴,Chemaitelly Hiam¹²,Ayoub Houssein H.⁵,Yassine Hadi M.⁶⁷,Benslimane Fatiha M.⁶⁷,Al Khatib Hebah A.⁶⁷,Tang Patrick⁸,Hasan Mohammad R.⁸,Coyle Peter⁶⁹¹⁰,Al Kanaani Zaina⁹,Al Kuwari Einas⁹,Jeremijenko Andrew⁹,Kaleeckal Anvar Hassan⁹,Latif Ali Nizar⁹,Shaik Riyazuddin Mohammad⁹,Abdul Rahim Hanan F.¹¹,Nasrallah Gheyath K.⁶⁷,Al Kuwari Mohamed Ghaith¹²,Butt Adeel A.³⁹,Al Romaihi Hamad Eid¹³,Al-Thani Mohamed H.¹³,Al Khal Abdullatif⁹,Bertollini Roberto¹³

Affiliation:

1. Infectious Disease Epidemiology Group, Weill Cornell Medicine–Qatar, Cornell University, Doha, Qatar

2. World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine–Qatar, Cornell University, Qatar Foundation–Education City, Doha, Qatar

3. Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, New York

4. Department of Public Health, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar

5. Mathematics Program, Department of Mathematics, Statistics, and Physics, College of Arts and Sciences, Qatar University, Doha, Qatar

6. Biomedical Research Center, Member of QU Health, Qatar University, Doha, Qatar

7. Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar

8. Department of Pathology, Sidra Medicine, Doha, Qatar

9. Hamad Medical Corporation, Doha, Qatar

10. Wellcome-Wolfson Institute for Experimental Medicine, Queens University, Belfast, United Kingdom

11. College of Health Sciences, QU Health, Qatar University, Doha, Qatar

12. Primary Health Care Corporation, Doha, Qatar

13. Ministry of Public Health, Doha, Qatar

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jama/articlepdf/2785918/jama_aburaddad_2021_oi_210122_1637269030.96237.pdf

Reference29 articles.

1. Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose.;Reynolds;Science,2021

2. SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study.;Letizia;Lancet Respir Med,2021

3. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine.;Polack;N Engl J Med,2020

4. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine.;Baden;N Engl J Med,2021

5. Effectiveness of the BNT162b2 COVID-19 vaccine against the B.1.1.7 and B.1.351 variants.;Abu-Raddad;N Engl J Med,2021

Cited by 134 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protection afforded by post-infection SARS-CoV-2 vaccine doses: a cohort study in Shanghai;2024-01-10

2. Design and analysis heterogeneity in observational studies of COVID-19 booster effectiveness: A review and case study;Science Advances;2023-12-22

3. Persistence of antibody responses to COVID-19 vaccines among participants in the COVID-19 Community Research Partnership;Vaccine: X;2023-12

4. Long Term Assessment of Anti-SARS-CoV-2 Immunogenicity after mRNA Vaccine in Persons Living with HIV;Vaccines;2023-11-22

5. Risk of SARS-CoV-2 infection and hospitalization in individuals with natural, vaccine-induced and hybrid immunity: a retrospective population-based cohort study from Estonia;Scientific Reports;2023-11-21